For a while now, we've known that a compound found in red wine called resveratrol has anti-inflammatory effects that could be beneficial in conditions such as heart disease and arthritis. It came to my attention originally as it is known to inhibit the cyclooxygenase (COX) enzyme family—which is how I pay my bills when I'm not writing for NI. In addition to blocking COX, resveratrol also blocks a pathway called NF-kB, a major component in the activation of many inflammatory genes. So far so good, and probably a reason why the French suffer from lower rates of cardiovascular disease than most other industrialized nations, despite eating lots of saturated fats.
But it seems that's not all that resveratrol does. It has also been known for quite some time that a low-calorie diet can extend lifespan, at least in rodents. This is achieved through the induction of a group of genes that encode the Sir2 family of NAD-dependent deacetylases. These enzymes help control and regulate the body's response to a low-calorie diet and influence fat metabolism, cell survival, insulin- and glucose production . All very interesting, but by now you're wondering what this has to do with red wine.
Quite a bit, as it turns out. An international team of scientists have discovered that resveratrol, in addition to its anti-inflammatory properties, is also a potent activator of SIRT1, one of the aforementioned genes involved in prolonging lifespan.
